Hemispherx Biopharma Exploring Possible Research Programs in Zika Virus Modeled on a Prior Alferon® N Clinical Trial on Closely Related Flavivirus (West Nile)
February 09, 2016 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Feb. 09, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) announced today that it is beginning to consider study designs for potential tests of the activity and...
Mosquitoes Continue to Pose Risk to Businesses Despite Dry Weather Conditions
July 31, 2012 08:27 ET
|
Terminix
MEMPHIS, Tenn., July 31, 2012 (GLOBE NEWSWIRE) -- Terminix, the world's largest pest control provider and a subsidiary of the ServiceMaster Company, encourages businesses with outdoor areas –...